Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7KFG

Antibody Fab BDBV-289

Summary for 7KFG
Entry DOI10.2210/pdb7kfg/pdb
DescriptorAntibody Fab BDBV-289 heavy chain, Antibody Fab BDBV-289 light chain, DI(HYDROXYETHYL)ETHER (3 entities in total)
Functional Keywordsebolavirus, antibody, broadly neutralizing, glycan cap, viral protein, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains2
Total formula weight47720.98
Authors
Murin, C.D.,Bruhn, J.F.,Ward, A.B. (deposition date: 2020-10-13, release date: 2021-04-28, Last modification date: 2024-11-13)
Primary citationMurin, C.D.,Gilchuk, P.,Ilinykh, P.A.,Huang, K.,Kuzmina, N.,Shen, X.,Bruhn, J.F.,Bryan, A.L.,Davidson, E.,Doranz, B.J.,Williamson, L.E.,Copps, J.,Alkutkar, T.,Flyak, A.I.,Bukreyev, A.,Crowe Jr., J.E.,Ward, A.B.
Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies.
Cell Rep, 35:108984-108984, 2021
Cited by
PubMed Abstract: Antibodies that target the glycan cap epitope on the ebolavirus glycoprotein (GP) are common in the adaptive response of survivors. A subset is known to be broadly neutralizing, but the details of their epitopes and basis for neutralization are not well understood. Here, we present cryoelectron microscopy (cryo-EM) structures of diverse glycan cap antibodies that variably synergize with GP base-binding antibodies. These structures describe a conserved site of vulnerability that anchors the mucin-like domains (MLDs) to the glycan cap, which we call the MLD anchor and cradle. Antibodies that bind to the MLD cradle share common features, including use of IGHV1-69 and IGHJ6 germline genes, which exploit hydrophobic residues and form β-hairpin structures to mimic the MLD anchor, disrupt MLD attachment, destabilize GP quaternary structure, and block cleavage events required for receptor binding. Our results provide a molecular basis for ebolavirus neutralization by broadly reactive glycan cap antibodies.
PubMed: 33852862
DOI: 10.1016/j.celrep.2021.108984
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.002 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon